Ryan Ford
- Department of Medicine
Associate Professor
- (404) 778-3184
Overview
Dr. Ford is committed to taking care of patients in Georgia with liver disease and has a particular interest in viral hepatitis, alcoholic liver disease, young adults with liver disease, and liver disease as a result of congenital heart disease. His goal is to continue to improve the practical approach to diagnosis and treatment of liver disease, and ultimately improve outcomes. One of Dr. Fords patients was the first patient at Emory to have a combined heart-liver-kidney transplant. Dr. Ford earned a Certificate of Added Qualification in Transplant Hepatology in 2010.
Academic Appointment
- Senior Physician, Emory University School of Medicine
- Assistant Professor, Emory University Department of Medicine, Emory University School of Medicine
Education
Degrees
- MD from Emory University School of Medicine
- BS from University of Georgia
- No Degree from Graceland College
Research
Focus
- Clinical management and outcomes of patients with chronic liver disease before and after liver transplantation
Publications
-
Hepatitis C donor positive to recipient negative solid organ transplants: Early direct acting antiviral insurance approval rates with and without documented viremia.
Am J Surg Volume: 226 Page(s): 239 - 244
08/01/2023 Authors: Duong AT; Snyder HS; Billmeyer AL; Cox AC; Cheng NL; Ford RM; Fuller KG -
Education and Psychosocial Factors Predict Odds of Death After Transfer to Adult health Care in Pediatric Liver Transplant Patients.
J Pediatr Gastroenterol Nutr Volume: 75 Page(s): 623 - 628
11/01/2022 Authors: Stevens JP; Gillespie S; Hall L; Tisheh J; Ford R; Gupta NA -
A TRANSITION PROGRAM AND NOVEL JOINT PEDIATRIC-ADULT CLINIC MODEL DECREASES ADULT MORTALITY IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS
Volume: 76 Page(s): S1546 - S1546
10/01/2022 Authors: Stevens J; Sadjadi R; Ford RM; Westbrook A; Gillespie S; Gupta NA -
Initial attendance and retention in adult healthcare as criteria for transition success among organ transplant recipients.
Pediatr Transplant Volume: 26 Page(s): e14280
08/01/2022 Authors: Rea KE; Cushman GK; Quast LF; George RP; Basu A; Ford R; Book W; Blount RL -
African American Pediatric Liver Transplant Recipients Have an Increased Risk of Death After Transferring to Adult Healthcare.
J Pediatr Volume: 233 Page(s): 119 - 125.e1
06/01/2021 Authors: Katz M; Gillespie S; Stevens JP; Hall L; Kolachala V; Ford R; Levin K; Gupta NA -
Death and Loss to Follow-up in Pediatric Liver Transplant Recipients Transferred to Adult Care: Who is at Risk?
Volume: 21 Page(s): 593 - 593
06/01/2021 Authors: Stevens JP; Gillespie S; Katz M; Hall L; Kolachala V; Ford R; Gupta NA -
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet Volume: 394 Page(s): 2184 - 2196
12/14/2019 Authors: Younossi ZM; Ratziu V; Loomba R; Rinella M; Anstee QM; Goodman Z; Bedossa P; Geier A; Beckebaum S; Newsome PN -
Digital Wings: Innovations in Transition Readiness for Adolescent and Young Adult Transplant Recipients [corrected].
Transplantation Volume: 103 Page(s): 1970 - 1974
10/01/2019 Authors: Mogul DB; Fredericks EM; Brady TM; Miloh T; Riekert K; Williams N; Ford R; Fergusson M; Kosmach-Park B; Hochstein J -
Hepatocellular Carcinoma in Fontan liver Disease.
Volume: 19 Page(s): 1076 - 1076
04/01/2019 Authors: Lamm V; Wedd J; Haydek C; Obineme C; Noll A; Veeramachaneni H; Muftah M; Ford R -
Frontiers in Fontan failure: Innovation and improving outcomes: A conference summary.
Congenit Heart Dis Volume: 14 Page(s): 128 - 137
03/01/2019 Authors: Ephrem G; Hebson C; John A; Moore E; Jokhadar M; Ford R; Veldtman G; Dori Y; Gurvitz M; Kogon B